shane kelly

Provide strategic insight, industry knowledge and best practices, and client support to rapidly growing consulting firm specializing in process, behavioral, and profit improvement in the energy, financial services, and healthcare sectors.

Full P&L responsibility for $200 million division with direct or matrix oversight of all functional areas for a multi-billion dollar leader in the design, manufacture, and marketing of products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Launched first next-generation FDA Class III non-invasive stimulation devices in more than 10 years by utilizing an in-house team covering design input and concept, software/hardware development, pilot and validation run, manufacturing transfer, and full product launch. Drove $13.5 million improvement in EBITDA Exceeded business plan and achieved high single-digit growth with critical spine product portfolio representing 40% of annual revenues. Stabilized bracing business in double-digit decline turned into single-digit gains; contribution margin improved from 59% to 62% along with a 15-point improvement in EBITDA from -8% to +7%.

Led sales function for global provider of non-invasive medical solutions focused on bone, joint, and soft tissue conditions. Developed diversification and expansion initiative including the completion of first 5-year strategic plan, establishing or collaborating with senior management to build all functional areas required to support an international business operating in 26 states and 8 foreign countries. Stabilized business facing a 43% decline in revenue; reversed trend resulting in 23% growth to nearly $62 million by expanding geographically and overhauling the sales management team. Turned under-performing, 12-station surgical lab into key cost center with over $1 million in revenue and 33% EBITDA. Convinced owner to exit the surgical business due to lack of profitability and strategic fit. Transitioned the business to J&J DePuy Mitek within 60 days and improved bottom line by $2.2 million.

Full P&L responsibility for FDA Class III medical device business for worldwide leader in solutions that promote musculoskeletal health. Led senior management team including VPs of Marketing, Manufacturing, Engineering, Medical/Regulatory/Compliance, Controller, and Director of HR. Orchestrated the closing of all Arizona operations and integration of the complete business unit - manufacturing and all administrative functions - into corporate offices in Vista, CA.

* Responsible for worldwide sales of $46 million in bone growth stimulation business with a team of 6 sales managers, 42 territory managers, 25 independent distributors, and contracted sales force (DePuy Spine, a Johnson & Johnson Co). * 2003: 21% top line growth and #1 growth position within industry. * 2002: 25% top line growth and #1 growth position within industry. * 2001: 50% top-line growth and #1 growth position within industry. * Played key role in divestiture of bone growth stimulation (BGS) business leading to the completion of $93 million asset purchase in November of 2003 and $65 million orthopedic rehabilitation division in July of 2001.

Constructed state-of-the-art dry cleaning plant and utilized the world’s only non-toxic, non-carcinogenic cleaning process, GreenEarth®, to process over 250,000 pieces. Built multi-unit Yelp/Google 5-star rated dry cleaning enterprise with revenues nearly quadruple the average dry cleaner in only 4 years. Generated 21% cash flow and achieved a final CAGR exceeding 60%. Sold business to one of three bidders at top of industry cash flow multiple.

Consulting services and management coaching in strategic planning, commercialization, operational scaling and improvement, raising capital, gap analysis, dashboards and KPIs, sales force effectiveness, hiring, training performance management, Situational Leadership®, and accelerating growth. Current and past clients: Aspen Medical Products, Beacon Biomedical, Biomet, Smart Brain Aging, Tempronics